|Articles|February 15, 0003

BioPharm International

  • BioPharm International-02-01-2003
  • Volume 16
  • Issue 2

Virus Inactivation in the 1990s ? and into the 21st Century: Part 5: Disinfection

by Gail Sofer, BioReliance Both the process and the product strongly influence viral inactivation, and unknown or unspecified details ? such as variability in virus titers, measuring devices, calibrations, and protocols ? can all influence log reduction values. This article series covers what you need to know to fully understand the properties of the test article, the viruses inactivated, and the critical control parameters for selected inactivation methods.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.